NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies
- PMID: 10963357
- DOI: 10.1007/s004010050002
NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies
Abstract
The co-localization of NACP/alpha-synuclein and tau epitopes was examined in the brain stem and hippocampal formation in two patients from a family of autosomal dominant parkinsonism and dementia with Lewy bodies (LBs) without two reported missense mutations in the NACP gene. Double-labeling immunofluorescence study revealed that some brain stem LBs, cortical LBs, pale bodies, Lewy-related neurites, and neurofibrillary tangles expressed both NACP epitopes and the PHF tau AT8 epitope. Double-immunolabeling electron microscopy demonstrated that the NACP antibody selectively labeled 9- to 13-nm-thick straight filaments (LB filaments), whereas AT8 recognized twisted tubules with 80-to 100-nm-interval constrictions in the same neuronal inclusions. We show that NACP and tau aggregate into different filamentous components even if both proteins are incorporated into the same inclusions.
Similar articles
-
Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.Brain Res. 1999 Oct 2;843(1-2):53-61. doi: 10.1016/s0006-8993(99)01848-x. Brain Res. 1999. PMID: 10528110
-
Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.Acta Neuropathol. 2001 Mar;101(3):285-93. doi: 10.1007/s004010000292. Acta Neuropathol. 2001. PMID: 11307630
-
Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.Brain Res. 1998 Oct 12;808(1):93-100. doi: 10.1016/s0006-8993(98)00734-3. Brain Res. 1998. PMID: 9795161
-
[Recent neuropathology of parkinsonian syndromes].Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S11-8. Rev Neurol (Paris). 2003. PMID: 12773883 Review. French.
-
Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.J Neurol Sci. 2000 Aug 1;177(1):48-59. doi: 10.1016/s0022-510x(00)00337-3. J Neurol Sci. 2000. PMID: 10967182 Review.
Cited by
-
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154. J Parkinsons Dis. 2024. PMID: 38143370 Free PMC article. Review.
-
Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism.MedComm (2020). 2023 Nov 20;4(6):e429. doi: 10.1002/mco2.429. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38020716 Free PMC article.
-
Interaction of Proteins Involved in Neuronal Proteinopathies.Life (Basel). 2023 Sep 23;13(10):1954. doi: 10.3390/life13101954. Life (Basel). 2023. PMID: 37895336 Free PMC article. Review.
-
Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system.Neural Regen Res. 2024 Apr;19(4):855-862. doi: 10.4103/1673-5374.382231. Neural Regen Res. 2024. PMID: 37843221 Free PMC article. Review.
-
Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model Dictyostelium discoideum.Front Cell Dev Biol. 2021 Sep 6;9:741662. doi: 10.3389/fcell.2021.741662. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34552934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
